The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study. Read more about The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study.
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database Read more about Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database
Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an international prophylaxis study group global survey. Read more about Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an international prophylaxis study group global survey.
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database Read more about Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database
Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an international prophylaxis study group global survey Read more about Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an international prophylaxis study group global survey
An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia Read more about An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia
An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia Read more about An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia
Laboratory Assay Measurement of Modified Clotting Factor Concentrates: A Review of the Literature and Recommendations for Practice Read more about Laboratory Assay Measurement of Modified Clotting Factor Concentrates: A Review of the Literature and Recommendations for Practice
Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis Read more about Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis
Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates Read more about Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates